HOME >> BIOLOGY >> NEWS
Enzyme discovery sheds light on vitamin D

KINGSTON, Ont. Surprising findings by Queens University researchers have shed new light on how the sunshine vitamin D increasingly used to treat and prevent cancer and other diseases is broken down by our bodies.

The effectiveness of vitamin D therapy is partly dependent on how quickly it will be broken down, says Biochemistry Professor Glenville Jones, an expert in the field of vitamin D metabolism. By studying the enzyme responsible for breaking down the vitamin, we hope to develop a way to prevent this from happening by blocking that response.

First observed in Dr. Joness lab by undergraduate Biochemistry student Brendan OLeary, the discovery reveals that changing a single amino acid in the hydroxylase enzyme will cause it to take a completely different pathway. Although scientists have known for 25 years that the enzyme is capable of taking two different pathways, until now they could not explain why this occurs.

The teams findings are published on-line in the journal Proceedings of the National Academy of Sciences (PNAS). Other members include: research associate David Prosser, PhD student Martin Kaufmann, and research technician Valarie Byford.

Earlier study of the enzyme had shown that its pathway pattern is species specific. Some species, including humans and rats, favour one pathway, while others most notably the opossum favour the other pathway.

Using a technique called liquid chromatography mass spectrometry, the researchers studied cells from animals in both categories. They changed the human enzyme in certain key places to see if this would affect its pathway pattern.

Surprisingly, they discovered that altering a single amino acid completely changes the enzyme from a human pattern to an opossum pattern. This change can be flicked back and forth like a light switch, says Dr. Jones, adding: Its remarkable. In biochemistry you rarely see that kind of predictive work from modeling mol
'"/>

Contact: Nancy Dorrance
nancy.dorrance@queensu.ca
613-533-2869
Queen's University
24-Jul-2007


Page: 1 2

Related biology news :

1. Enzyme delivered in smaller package protects cells from radiation damage
2. Enzyme Engineering XIX
3. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
4. Enzyme shreds Alzheimers protein
5. Enzyme defect leads to hyperinsulinism
6. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
7. Enzyme crystal structure reveals unexpected genome repair functions
8. Enzyme inhibitors block replication of SARS virus
9. Enzyme may be target for new anti-inflammatory compounds
10. Enzyme action creates protein linked to Alzheimers disease
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
Breaking Biology News(10 mins):
(Date:9/12/2017)... ... September 12, 2017 , ... September 15, ... that Jeremy Nicholson, Head of the Department of Surgery and Cancer and Director ... Wallace H. Coulter Lecture. His presentation, “Analytical Science in Precision Medicine: Facing ...
(Date:9/12/2017)... ... September 12, 2017 , ... Facet Life Sciences, a ... teams, today announced that Tobias Massa, PhD has joined the company’s Board of Directors. ... and technology to his Board position. Most recently he served as VP and Head ...
(Date:9/12/2017)... (PRWEB) , ... September 11, 2017 , ... ... health and financial burden associated with Sepsis, BD is sponsoring an educational webinar ... estimated 31 Million people worldwide, with an estimated five million deaths annually, is ...
(Date:9/12/2017)... ... September 12, 2017 , ... ... that accelerate pharmaceutical and biotherapeutics development, announces a new publication in ... R100 biosensor. Antibodies developed by the Centers for Disease Control (CDC) were used ...
Breaking Biology Technology:
Cached News: